Blood-based cancer biomarkers promise minimally invasive, longitudinal monitoring, yet their clinical utility varies profoundly by analyte class, disease stage, and analytical methodology. This Review critically evaluates six circulating biomarker classes, such as CTCs, ctDNA, cfDNA methylation, exosomes, circulating m...
Yi Zhang, Zhen Wang· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.